New Sponsorship Deal
PDGN is delighted to welcome Dexcom as a sponsor for Global Advocacy News. Dexcom. Inc is a company that develops, manufactures and distributes continuous glucose monitoring (CGM) systems for diabetes management.
Please note:
THE INCLUSION OF THIRD-PARTY ADVERTISEMENTS DOES NOT CONSTITUTE AN ENDORSEMENT, GUARANTEE, WARRANTY, OR RECOMMENDATION BY PDGN, AND WE MAKE NO REPRESENTATIONS OR WARRANTIES ABOUT ANY PRODUCT OR SERVICE CONTAINED THEREIN.
Pandemic or Syndemic? Following a comment piece in the Lancet where Richard Horton suggested COVID-19 wasn’t a Pandemic, but a Syndemic, a joint EFPIA/EUDF, online event was organised to consider the question.
PDGN was invited to join the online panel of experts under the heading: “Unlocking the potential of the European Health Data Space to improve diabetes management in crises and beyond”
It drew out the way that COVID and non-communicable diseases (NCD’s), like diabetes, co-exist with some of the wider issues of health care.
A ‘syndemic’ was explained as different from a ‘pandemic’ in that conditions do not act in isolation, but are caused by a combination of environment, social and economic factors that perhaps explain the link between COVID-19 and NCD’s like diabetes among minority ethnic groups, low income households, poor living conditions.
PDGN Secretary General, Adrian Sanders, joined the panel and gave an overview of how different countries are coping with COVID-19 and diabetes. He spoke on the importance of having well-informed politicians about data sharing who can influence policies that tackle the multitude of challenges in an holistic manner.
Global Advocacy Diabetes is the newsletter for members and friends of PDGN, the Parliamentarians for Diabetes Global Network. Our primary objective is to enable law-makers to help prevent diabetes, encourage early diagnosis of diabetes and improve the treatment of diabetes in every part of the world. We exist to help advocates for diabetes and its comorbidities wherever they are.